Cancer models in preclinical research: A chronicle review of advancement in effective cancer research

Animal Models and Experimental Medicine

Humna Sajjad¹  Saiqa Imtiaz¹  Tayyaba Noor¹  Muhammad Zia¹  Yusra Hasan Siddiqui¹  Anila Sajjad¹ 

[1] Department of Biotechnology Quaid‐i‐Azam University Islamabad Pakistan;

关键词: cancer cell lines;    computational cancer models;    genetically engineered mouse models;    organoids;    patient‐derived xenografts;    personalized medicine;   

DOI  :  10.1002/ame2.12165

来源: DOAJ

【 摘 要 】

Abstract Cancer is a major stress for public well‐being and is the most dreadful disease. The models used in the discovery of cancer treatment are continuously changing and extending toward advanced preclinical studies. Cancer models are either naturally existing or artificially prepared experimental systems that show similar features with human tumors though the heterogeneous nature of the tumor is very familiar. The choice of the most fitting model to best reflect the given tumor system is one of the real difficulties for cancer examination. Therefore, vast studies have been conducted on the cancer models for developing a better understanding of cancer invasion, progression, and early detection. These models give an insight into cancer etiology, molecular basis, host tumor interaction, the role of microenvironment, and tumor heterogeneity in tumor metastasis. These models are also used to predict novel cancer markers, targeted therapies, and are extremely helpful in drug development. In this review, the potential of cancer models to be used as a platform for drug screening and therapeutic discoveries are highlighted. Although none of the cancer models is regarded as ideal because each is associated with essential caveats that restraint its application yet by bridging the gap between preliminary cancer research and translational medicine. However, they promise a brighter future for cancer treatment.

【 授权许可】

Unknown